Risk Management

Failure to diagnose Giant Cell Arteritis results in settlement

OMIC has seen several sizeable settlements resulting from failure to diagnose giant cell arteritis cases in the past few years. In 2020, alone, there were two large settlements, this one for $475K and another case for $600K. The settlements are large because GCA, if diagnosis does not occur or is delayed, often leads to bilateral blindness in elderly patients. 

Allegation: Failure to diagnose giant cell arteritis in a 79-year-old. 

Disposition: Settlement of $475K. 

Read the entire treatment history, analyses, and takeaways from these two claims on pg. 6 of the 2022 Digest Vol 32 N0 1.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.